Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
WST
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
+1.94%
$221.20+4.22Delayed quote: Aug 11, 2026, 4:00 PM EDT
Market Cap
$29.60B
52W Range
$197.81 - $495.55
WST
West Pharmaceutical Services, Inc.
-0.22%
$351.37-0.76Delayed quote: Aug 11, 2026, 4:02 PM EDT
Market Cap
$24.73B
52W Range
$223.83 - $386.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 36.65 | 45.03 |
| Forward P/E | 32.08 | 39.38 |
| P/B Ratio | 22.15 | 8.40 |
| P/S Ratio | 6.24 | 7.55 |
| P/FCF Ratio | 55.29 | 57.47 |
| EV/EBITDA | 28.04 | 28.82 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 36.8% |
| Operating Margin | 20.8% | 20.6% |
| Net Margin | 16.8% | 17.0% |
| ROE | 59.7% | 18.9% |
| ROA | 14.5% | 13.9% |
| ROIC | 13.7% | 13.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 2.82 |
| Quick Ratio | 2.99 | 2.12 |
| Debt/Equity | 0.94 | 0.10 |
| Interest Coverage | 1.99 | 1029.00 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 0.3% |
| Payout Ratio | N/A | 12.9% |
| Yrs of Dividend Growth | 0 | 33 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.